ERBB2 and breast cancer: To study the impact of EDI3 on processes that may be important for tumor metastasis in ER-HER2+ breast cancer, we used luciferase-positive HCC1954 cells into which we stably transfected doxycycline-inducible shRNA constructs (Fig. 1A) [6].